We are live on
!
Find out more
Federated Hermes Portfolio holdings
AUM
$69.6B
Turnover
16.03%
1-Year Est. Return
42.52%
This Fund
S&P 500
This Quarter
Est. Return
+13.69%
1 Year Est. Return
+42.52%
3 Year Est. Return
+132.48%
5 Year Est. Return
+152.58%
10 Year Est. Return
+652.43%
AUM
$53.1B
AUM Growth
+$6.76B
(+15%)
Cap. Flow
+$2.33B
Cap. Flow
% of AUM
4.39%
Top 10 Holdings %
Top 10 Hldgs %
14.65%
Holding
2,220
New
169
Increased
729
Reduced
1,033
Closed
165
Avg Time Held
5.4
years
Top 10 Avg Time Held
1.7
years
Top 20 Avg Time Held
2.5
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zscaler
ZS
|
+$222M |
| 2 |
Palantir
PLTR
|
+$221M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$213M |
| 4 |
FirstEnergy
FE
|
+$189M |
| 5 |
Broadcom
AVGO
|
+$174M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$383M |
| 2 |
Philip Morris
PM
|
+$280M |
| 3 |
Entergy
ETR
|
+$207M |
| 4 |
Paychex
PAYX
|
+$206M |
| 5 |
Gilead Sciences
GILD
|
+$201M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.81% |
| 2 | Healthcare | 14.57% |
| 3 | Financials | 13.43% |
| 4 | Industrials | 10.29% |
| 5 | Consumer Discretionary | 9.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
676
Bank of N.T. Butterfield & Son
NTB
$2.29B
| $6.11M | 0.01% |
137,993
+75,668
| +121% | +$3.1M |
2024 Q3
3 quarters
|
|
677
Redwire
RDW
$2.23B
| $6.11M | 0.01% |
374,739
-123,407
| -25% | -$1.61M |
2024 Q1
5 quarters
|
|
678
US Foods
USFD
$22B
| $6.1M | 0.01% |
79,178
-12,010
| -13% | -$857K |
2021 Q4
14 quarters
|
|
679
Griffon
GFF
$4.22B
| $6.1M | 0.01% |
84,228
-16,451
| -16% | -$1.15M |
2023 Q3
7 quarters
|
|
680
STAAR Surgical
STAA
$1.12B
| $6.1M | 0.01% |
+363,233
| New | +$6.4M |
2025 Q2
0 quarters
|
|
681
Neogen
NEOG
$2.68B
| $6.04M | 0.01% |
+1,263,289
| New | +$7.25M |
2025 Q2
0 quarters
|
|
682
First Financial Bankshares
FFIN
$4.53B
| $5.99M | 0.01% |
166,554
-3,925
| -2% | -$136K |
2018 Q3
27 quarters
|
|
683
Robinhood
HOOD
$93.5B
| $5.99M | 0.01% |
63,957
+32,933
| +106% | +$1.95M |
2024 Q3
3 quarters
|
|
684
Stanley Black & Decker
SWK
$14B
| $5.98M | 0.01% |
88,277
+40,449
| +85% | +$2.61M |
2022 Q3
11 quarters
|
|
685
Commercial Metals
CMC
$7.23B
| $5.97M | 0.01% |
122,106
-21,484
| -15% | -$995K |
2013 Q2
48 quarters
|
|
686
Myriad Genetics
MYGN
$416M
| $5.96M | 0.01% |
1,122,333
+1,121,254
| +103,916% | +$6.62M |
2020 Q1
21 quarters
|
|
687
TechnipFMC
FTI
$26.8B
| $5.94M | 0.01% |
172,551
-11,356
| -6% | -$343K |
2022 Q4
10 quarters
|
|
688
Everforth Inc
EFOR
$1.62B
| $5.92M | 0.01% |
118,613
+114,418
| +2,727% | +$6.25M |
2018 Q2
28 quarters
|
|
689
Axsome Therapeutics
AXSM
$8.47B
| $5.89M | 0.01% |
56,469
+30,479
| +117% | +$3.23M |
2025 Q1
1 quarter
|
|
690
American Water Works
AWK
$26.4B
| $5.89M | 0.01% |
42,353
-4,300
| -9% | -$616K |
2015 Q3
39 quarters
|
|
691
Krystal Biotech
KRYS
$9.77B
| $5.88M | 0.01% |
42,743
+29,962
| +234% | +$4.4M |
2024 Q3
3 quarters
|
|
692
HP
HPQ
$27.8B
| $5.86M | 0.01% |
239,517
-242,579
| -50% | -$6.18M |
2013 Q2
48 quarters
|
|
693
LivaNova
LIVN
$4.32B
| $5.85M | 0.01% |
129,866
-14,250
| -10% | -$588K |
2015 Q4
38 quarters
|
|
694
AXIS Capital
AXS
$7.15B
| $5.84M | 0.01% |
56,212
+811
| +1% | +$80.7K |
2017 Q1
33 quarters
|
|
695
DELISTED
Janus Henderson
JHG
| $5.82M | 0.01% |
149,822
+4,256
| +3% | +$150K |
2017 Q2
32 quarters
|
|
696
Seadrill
SDRL
$2.9B
| $5.8M | 0.01% |
221,040
+220,984
| +394,614% | +$5.22M |
2025 Q1
1 quarter
|
|
697
Jacobs Solutions
J
$16.6B
| $5.8M | 0.01% |
44,097
-457
| -1% | -$56.3K |
2020 Q2
20 quarters
|
|
698
Pitney Bowes
PBI
$2.37B
| $5.73M | 0.01% |
525,512
+7,292
| +1% | +$68.6K |
2013 Q2
48 quarters
|
|
699
DTE Energy
DTE
$26.7B
| $5.72M | 0.01% |
43,192
+935
| +2% | +$126K |
2013 Q2
48 quarters
|
|
700
VF Corp
VFC
$6.68B
| $5.66M | 0.01% |
481,910
+397,097
| +468% | +$4.92M |
2013 Q2
48 quarters
|
|
Similar funds
Federated Hermes's Q2 2025 Portfolio in Review
As of Q2 2025, Federated Hermes held 2,220 positions worth $53.1B, up 15% from $46.4B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Federated Hermes deployed $2.33B of net new capital in Q2 2025, opening 169 new positions and adding to 729 existing holdings. Its largest new stake was Genuine Parts: 882,160 shares worth $107M.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 20% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Bristol-Myers Squibb, an estimated $383M trimmed.
- Federated Hermes's largest Q2 2025 buy was Genuine Parts: 882,160 shares worth $107M.
- Federated Hermes added most to Zscaler in Q2 2025, an estimated $222M increase.
- Federated Hermes's biggest Q2 2025 reduction was Bristol-Myers Squibb, cutting an estimated $383M.
- Federated Hermes fully exited Regulus Therapeutics in Q2 2025, selling an estimated $39.2M.
- Federated Hermes's ten largest holdings make up 15% of its $53.1B portfolio in Q2 2025.
- Federated Hermes opened 169 new positions and closed 165 in Q2 2025.
- Federated Hermes's portfolio value rose 15% quarter-over-quarter to $53.1B.
Based on Federated Hermes's 13F filing for Q2 2025, filed 13 Aug 2025.